Bio-Techne (TECH) Misses Q1 EPS by 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts TECH Hot Sheet
Price: $72.66 -0.01%
Financial Fact:
Operating income: 25.44M
Today's EPS Names:
FUSE, INM, TRI, More
Financial Fact:
Operating income: 25.44M
Today's EPS Names:
FUSE, INM, TRI, More
Join SI Premium – FREE
Bio-Techne (NASDAQ: TECH) reported Q1 EPS of $0.79, $0.06 worse than the analyst estimate of $0.85. Revenue for the quarter came in at $12.4 million versus the consensus estimate of $116.4 million.
For earnings history and earnings-related data on Bio-Techne (TECH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ultragenyx Pharma (RARE) Misses Q3 EPS by 6c; Offers Guidance
- Limbach Holdings (LMB) Tops Q3 EPS by 16c, Beats on Revenue; Offers FY26 Revenue Guidance
- Essential Utilities, Inc. (WTRG) Tops Q3 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
